185. Saihara K, Kamikubo R, Ikemoto K, Uchida K, Akagawa M. Pyrroloquinoline quinone, a redox-active o-quinone, stimulates mitochondrial biogenesis by activating the SIRT1/PGC-1α signaling pathway. Biochemistry. 2017;56:6615–25. https://pubmed.ncbi.nlm.nih.gov/29185343/186
186. Hwang P, Willoughby DS. Mechanisms behind pyrroloquinoline quinone supplementation on skeletal muscle mitochondrial biogenesis: possible synergistic effects with exercise. J Am Coll Nutr. 2018;37:738–48. https:// pubmed.ncbi.nlm.nih.gov/29714638/
187. Nakano M, Yamamoto T, Okamura H, Tsuda A, Kowatari Y. Effects of oral supplementation with pyrroloquinoline quinone on stress, fatigue, and sleep. Functional Foods in Health and Disease. 2012;2:307–24. https://www.ffhdj.com/index.php/ffhd/article/view/81
188. Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM, Rucker RB. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem. 2013;24:2076–84. https://pubmed.ncbi.nlm.nih.gov/ 24231099/
189. de Oliveira MR, Nabavi SM, Braidy N, Setzer WN, Ahmed T, Nabavi SF. Quercetin and the mitochondria: a mechanistic view. Biotechnol Adv. 2016;34:532–49. https://pubmed.ncbi.nlm.nih.gov/26740171/
190. Davis JM, Murphy EA, Carmichael MD, Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol. 2009;296:R1071–77. https://pubmed.ncbi.nlm.nih.gov/19211721/
191. Pelletier DM, Lacerte G, Goulet EDB. Effects of quercetin supplementation on endurance performance and maximal oxygen consumption: a metaanalysis. Int J Sport Nutr Exerc Metab. 2013;23:73–82. https://pubmed.ncbi.nlm.nih.gov/22805526/
192. Kressler J, Millard-Stafford M, Warren GL. Quercetin and endurance exercise capacity: a systematic review and meta-analysis. Med Sci Sports Exerc. 2011;43:2396–404. https://pubmed.ncbi.nlm.nih.gov/21606866/
193. Ou Q, Zheng Z, Zhao Y, Lin W. Impact of quercetin on systemic levels of inflammation: a meta-analysis of randomised controlled human trials. Int J Food Sci Nutr. 2020;71:152–63. https://pubmed.ncbi.nlm.nih.gov/31213101/
194. Mohammadi-Sartang M, Mazloom Z, Sherafatmanesh S, Ghorbani M, Firoozi D. Effects of supplementation with quercetin on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2017;71:1033–99. https://pubmed.ncbi.nlm.nih.gov/28537580/
195. Tabrizi R, Tamtaji OR, Mirhosseini N, Lankarani KB, Akbari M, Heydari ST, et al. The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60:1855–68. https://pubmed.ncbi.nlm.nih.gov/31017459/
196. Guo W, Gong X, Li M. Quercetin actions on lipid profiles in overweight and obese individuals: a systematic review and meta-analysis. Curr Pharm Des. 2019;25:3087–95. https://pubmed.ncbi.nlm.nih.gov/31465275/
197. Sahebkar A. Effects of quercetin supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2017;57:666–76. https://pubmed.ncbi.nlm.nih.gov/25897620/
198. Tamtaji OR, Milajerdi A, Dadgostar E, Kolahdooz F, Chamani M, Amirani E, et al. The effects of quercetin supplementation on blood pressures and endothelial function among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des. 2019;25:1372–84. https://pubmed.ncbi.nlm.nih.gov/ 31092175/
199. Serban M-C, Sahebkar A, Zanchetti A, Mikhailidis DP, Howard G, Antal D, et al. Effects of quercetin on blood pressure: a systematic review and metaanalysis of randomized controlled trials. J Am Heart Assoc. 2016;5. http:// dx.doi.org/10.1161/JAHA.115.002713
200. Riva A, Ronchi M, Petrangolini G, Bosisio S, Allegrini P. Improved oral absorption of quercetin from Quercetin Phytosome®, a new delivery system based on food grade lecithin. Eur J Drug Metab Pharmacokinet. 2019;44:169– 77. https://pubmed.ncbi.nlm.nih.gov/30328058/
201. Singh N, Bhalla M, de Jager P, Gilca M. An overview on Ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011;8:208–13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252722/
202. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med. 2014;20:901–8. https://pubmed.ncbi.nlm.nih.gov/25405876/
203. Andrade C. Ashwagandha for anxiety disorders. World J. Biol. Psychiatry. 2009;10(4 Pt2):686–87. https://pubmed.ncbi.nlm.nih.gov/19363747/
204. Zahiruddin S, Basist P, Parveen A, Parveen R, Khan W, Gaurav, et al. Ashwagandha in brain disorders: A review of recent developments. J Ethnopharmacol. 2020;257:112876. https://pubmed.ncbi.nlm.nih.gov/ 32305638/
205. Candelario M, Cuellar E, Reyes-Ruiz JM, Darabedian N, Feimeng Z, Miledi R, et al. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. J Ethnopharmacol. 2015;171:264–72. https://pubmed.ncbi.nlm.nih.gov/26068424/
206. Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of Ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019;11:e6466. https://pubmed.ncbi.nlm.nih.gov/32021735/
207. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and safety of Ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus. 2019;11:e5797. https://pubmed.ncbi.nlm.nih.gov/31728244/
208. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized doubleblind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34:255–62. https://pubmed.ncbi.nlm.nih.gov/23439798/
209. Fuladi S, Emami SA, Mohammadpour AH, Karimani A, Manteghi AA, Sahebkar A. Assessment of Withania somnifera root extract efficacy in patients with generalized anxiety disorder: a randomized double-blind placebo-controlled trial. Curr Clin Pharmacol. 2021;16(2):191–96. https:// pubmed.ncbi.nlm.nih.gov/32282308/
210. Salve, Pate, Debnath, Langade. Adaptogenic and anxiolytic effects of Ashwagandha root extract.
211. Kelgane SB, Salve J, Sampara P, Debnath K. Efficacy and tolerability of Ashwagandha root extract in the elderly for improvement of general wellbeing and sleep: a prospective, randomized, double-blind, placebo-controlled study. Cureus. 2020;12:e7083. https://pubmed.ncbi.nlm.nih.gov/32226684/
212. Langade. Efficacy and safety of Ashwagandha (Withania somnifera) root extract in insomnia and anxiety.
213. Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stressrelieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine. 2019;98:e17186. https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC6750292/
214. Larsen C, Shahinas J. Dosage, efficacy and safety of cannabidiol administration in adults: a systematic review of human trials. J Clin Med Res. 2020;12:129–41. https://pubmed.ncbi.nlm.nih.gov/32231748/
215. VanDolah HJ, Bauer BA, Mauck KF. Clinicians’ guide to cannabidiol and hemp oils. Mayo Clin Proc. 2019;94:1840–51. https://pubmed.ncbi.nlm.nih.gov/31447137/
216. Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19:23. https://pubmed.ncbi.nlm.nih.gov/28349316/
217. Murillo-Rodriguez E, Blanco-Centurion C, Sanchez C, Piomelli D, Shiromani PJ. Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep. 2003;26:943–47. https://pubmed.ncbi.nlm.nih.gov/14746372/
218. Monti JM. Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology. 1977;55:263–65. https://pubmed.ncbi.nlm.nih.gov/ 414288/
219. Chagas MHN, Eckeli AL, Zuardi AW, Pena-Pereira MA, Sobreira-Neto MA, Sobreira ET, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. J Clin Pharm Ther. 2014;39:564–66. https:// pubmed.ncbi.nlm.nih.gov/24845114/
220. Shannon S, Opila-Lehman J. Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. Perm J. 2016;20:16–005. https://pubmed.ncbi.nlm.nih.gov/27768570/
221. Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18–041. https://pubmed.ncbi.nlm.nih.gov/ 30624194/
222. Srivastava JK, Shankar E, Gupta S. Chamomile: a herbal medicine of the past with bright future. Mol Med Rep. 2010;3:895–901. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995283/
223. Hieu TH, Dibas M, Surya Dila KA, Sherif NA, Hashmi MU, Mahmoud M, et al. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: a systematic review and meta-analysis of randomized trials and quasi-randomized trials. Phytother Res. 2019;33:1604–15. https://pubmed.ncbi.nlm.nih.gov/ 31006899/
224. Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29:378–82. https://pubmed.ncbi.nlm.nih.gov/19593179/